On Nov 4, 2021 Hale Therapeutics closed a Angel round and raised $200,000 from Robert Corrato, Robert Keith, featuring lead investors Robert Corrato, Robert Keith. […]
Series B – Neuro-ID
On Nov 4, 2021 Neuro-ID closed a Series B round and raised $35,000,000 from Canapi Ventures, Fin Venture Capital, TTV Capital, featuring lead investors Canapi […]
Post-IPO Equity – XOMA
On Nov 4, 2021 XOMA closed a Post-IPO Equity round and raised $35,000,000 from Novartis, featuring lead investors Novartis. About the company: XOMA is located […]
Series A – Primmune Therapeutics
On Nov 4, 2021 Primmune Therapeutics closed a Series A round and raised $8,400,000 from investors, featuring lead investors . About the company: Primmune Therapeutics […]
Series B – Molecular Assemblies
On Nov 4, 2021 Molecular Assemblies closed a Series B round and raised $10,000,000 from SynBio Innovation Accelerator, featuring lead investors SynBio Innovation Accelerator. About […]
Seed Round – Naturaz
On Nov 4, 2021 Naturaz closed a Seed round and raised $225,000 from Max Kanevsky, Michael G. Wells, Mikal C Harden, Robert Corrato, Robert Keith, […]
Venture Round – B-Secur
On Nov 4, 2021 B-Secur closed a Venture – Series Unknown round and raised £8,800,000 from Co-FundNI, First Capital Ventures, Kernel Capital, Wharton Asset Management […]
Grant – MigVax
On Nov 4, 2021 MigVax closed a Grant round and raised $3,400,000 from Coalition for Epidemic Preparedness Innovations, featuring lead investors Coalition for Epidemic Preparedness […]
Venture Round – Valera Health
On Nov 4, 2021 Valera Health closed a Venture – Series Unknown round and raised $15,000,000 from Alsora Capital, Aquiline Technology Growth, AXA Venture Partners, […]
Post-IPO Equity – XOMA
On Nov 4, 2021 XOMA closed a Post-IPO Equity round and raised $35,000,000 from Novartis, featuring lead investors Novartis. About the company: XOMA is located […]
